Murugesan, Natesan published the artcileBiphenylsulfonamide endothelin receptor antagonists: discovery of 4′-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ETA antagonists, Computed Properties of 72571-06-3, the publication is Journal of Medicinal Chemistry (2000), 43(16), 3111-3117, database is CAplus and MEDLINE.
The synthesis and structure-activity relationship (SAR) studies of a series of 4′-oxazolyl-N-(3,4-dimethyl-5-isoxazolyl)[1,1′-biphenyl]-2-sulfonamide derivatives as endothelin-A (ETA) receptor antagonists are described. The data reveal a remarkable improvement in potency and metabolic stability when the 4′-position of the biphenylsulfonamide is substituted with an oxazole ring. Addnl. 2′-substitution of an acylaminomethyl group further increased the binding activity and provided one of the first subnanomolar ETA-selective antagonists in the biphenylsulfonamide series (ETA Ki = 0.2 nM). Among the compounds described, (N-(3,4-dimethyl-5-isoxazolyl)-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulfonamide; BMS-193884) had the optimum pharmacol. profile and was therefore selected as a clin. candidate for studies in congestive heart failure.
Journal of Medicinal Chemistry published new progress about 72571-06-3. 72571-06-3 belongs to oxazolidine, auxiliary class Oxazole,Bromide,Benzene, name is 5-(4-Bromophenyl)oxazole, and the molecular formula is C9H6BrNO, Computed Properties of 72571-06-3.
Referemce:
https://en.wikipedia.org/wiki/Oxazolidine,
Oxazolidine | C3H7NO – PubChem